Ozmosis Research (Canada)

Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

Sarit Assouline, Torsten Holm Nielsen, Stephen Yu et al. · Blood · 2016 · 140 citations · Full text

Medicine, Hematology, Oncology +9

EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression

Stéphanie Lheureux, Ana Oaknin, Swati Garg et al. · Clinical Cancer Research · 2020 · 132 citations · Full text

Medicine, Oncology, Pharmacology +16

Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study

Patrick Cheung, Samir Patel, Scott North et al. · European Urology · 2021 · 125 citations

Medicine, Oncology, Radiation Oncology +16

Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial

Hagen F. Kennecke, Scott Berry, Chen Zhou et al. · European Journal of Cancer · 2011 · 71 citations · Full text

Medicine, Oncology, Surgery +16

Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial

Brett L. Houston, Patrick R. Lawler, Ewan C. Goligher et al. · Clinical Trials · 2020 · 68 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17